BR112022024932A2 - Vacina contra vírus da influenza a suína compreendendo um constructo de ácido nucleico que possui uma ordem específica de genes - Google Patents
Vacina contra vírus da influenza a suína compreendendo um constructo de ácido nucleico que possui uma ordem específica de genesInfo
- Publication number
- BR112022024932A2 BR112022024932A2 BR112022024932A BR112022024932A BR112022024932A2 BR 112022024932 A2 BR112022024932 A2 BR 112022024932A2 BR 112022024932 A BR112022024932 A BR 112022024932A BR 112022024932 A BR112022024932 A BR 112022024932A BR 112022024932 A2 BR112022024932 A2 BR 112022024932A2
- Authority
- BR
- Brazil
- Prior art keywords
- nucleic acid
- acid construct
- swine influenza
- vaccine
- genes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36141—Use of virus, viral particle or viral elements as a vector
- C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
VACINA CONTRA VÍRUS DA INFLUENZA A SUÍNA COMPREENDENDO UM CONSTRUCTO DE ÁCIDO NUCLEICO QUE POSSUI UMA ORDEM ESPECÍFICA DE GENES. A presente invenção está relacionada a um construto de ácido nucleico que codifica, nesta ordem, um primeiro antígeno de hemaglutinina (HA) de influenza A suína (IAV-S) da linhagem Scot/94 e um segundo antígeno de hemaglutinina (HA) de influenza A suína (IAV-S) da linhagem tipo ave da Eurásia (EA) e um construto de ácido nucleico que codifica, nesta ordem, um primeiro antígeno de HA de IAV-S da linhagem Gent/84 e um segundo antígeno de HA de IAV-S da linhagem pandemic09 (pdm09). Em outras modalidades, a presente invenção está relacionada a partículas de replicon de RNA compreendendo um ou ambos os construtos de ácido nucleico, uma composição imunogênica, tal como uma vacina, que pode ser usada contra infecções pelo vírus da influenza A e compreende as partículas de replicon. Além disso, são fornecidos métodos para fazer a vacina e o uso da vacina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20181094 | 2020-06-19 | ||
PCT/EP2021/066546 WO2021255219A1 (en) | 2020-06-19 | 2021-06-18 | Swine influenza a virus vaccine comprising a nucleic acid construct having a specific order of genes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022024932A2 true BR112022024932A2 (pt) | 2022-12-27 |
Family
ID=71170243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022024932A BR112022024932A2 (pt) | 2020-06-19 | 2021-06-18 | Vacina contra vírus da influenza a suína compreendendo um constructo de ácido nucleico que possui uma ordem específica de genes |
Country Status (6)
Country | Link |
---|---|
US (1) | US20230265130A1 (pt) |
EP (1) | EP4168041A1 (pt) |
JP (1) | JP2023530133A (pt) |
CN (1) | CN115768472A (pt) |
BR (1) | BR112022024932A2 (pt) |
WO (1) | WO2021255219A1 (pt) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005245956B2 (en) | 2004-05-18 | 2011-05-19 | Alphavax, Inc. | TC-83-derived alphavirus vectors, particles and methods |
US7850977B2 (en) | 2007-06-21 | 2010-12-14 | Alphavax, Inc. | Promoterless cassettes for expression of alphavirus structural proteins |
TWI551295B (zh) | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌(Lawsonia intracellularis)用疫苗 |
TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗 |
EA201990717A1 (ru) * | 2016-09-20 | 2019-10-31 | Новая вакцина против гриппа свиней | |
JP7289265B2 (ja) * | 2016-10-26 | 2023-06-09 | キュアバック エスイー | 脂質ナノ粒子mRNAワクチン |
-
2021
- 2021-06-18 CN CN202180043371.6A patent/CN115768472A/zh active Pending
- 2021-06-18 BR BR112022024932A patent/BR112022024932A2/pt unknown
- 2021-06-18 EP EP21732914.3A patent/EP4168041A1/en active Pending
- 2021-06-18 JP JP2022577343A patent/JP2023530133A/ja active Pending
- 2021-06-18 US US18/010,418 patent/US20230265130A1/en active Pending
- 2021-06-18 WO PCT/EP2021/066546 patent/WO2021255219A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021255219A1 (en) | 2021-12-23 |
JP2023530133A (ja) | 2023-07-13 |
CN115768472A (zh) | 2023-03-07 |
EP4168041A1 (en) | 2023-04-26 |
US20230265130A1 (en) | 2023-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chivukula et al. | Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza | |
BR112022026733A2 (pt) | Imunógenos estabilizados de proteína spike (s) de coronavírus e vacinas relacionadas | |
MX2022009429A (es) | Composiciones para la inmunizacion contra virus respiratorios. | |
CY1118080T1 (el) | Σωματιδια απελευθερωσης που ομοιαζουν με ιικα σωματιδια για αυτοαντιγραφικα rna μορια | |
BR112017014219A2 (pt) | vacinas à base de nanopartículas multivalentes | |
AR068507A1 (es) | Construcciones vector fluorocarbonado-antigeno para el suministro de antigenos ifluenza | |
AR056133A1 (es) | Virus de influenza canina y composiciones relacionadas y metodos de uso | |
BR112012008000A2 (pt) | excipiente estabilzante para vacina com vírus plenos inativados | |
BRPI0513390A (pt) | vacinas contra aids contendo construções de ácido nucléico cmv/r | |
CL2018003178A1 (es) | Composición farmacéutica | |
BR112019009133A2 (pt) | vacina contra o parvovírus suíno | |
DOP2010000189A (es) | Vacunas contra la malaria | |
BR112018068342A2 (pt) | vacina de vírus zika vivo atenuado | |
CL2020001901A1 (es) | Vacunas contra virus de la gripe y usos de las mismas. | |
BR112017015288A2 (pt) | vacina contra febre aftosa | |
BR112023005043A2 (pt) | Vacina contra covid-19 à base de piv5 | |
WO2020035609A3 (en) | Immunogenic compositions and uses thereof | |
BR112022022859A2 (pt) | Vacinas contra sars-cov-2 | |
MX2022012251A (es) | Vacuna universal contra la influenza usando arnm modificado con nucleósidos. | |
CO2023015036A2 (es) | Composición inmunogénica contra la influenza | |
BR112022024932A2 (pt) | Vacina contra vírus da influenza a suína compreendendo um constructo de ácido nucleico que possui uma ordem específica de genes | |
BR112022025678A2 (pt) | Vacina contra o vírus da influenza a suína compreendendo duas partículas de replicon de rna distintas | |
UY39310A (es) | Acido nucleico y secuencias de aminoácidos de adenovirus de gorila, vectores que los contienen, usos de los mismos | |
BR112018013014A2 (pt) | composições de higiene pessoal | |
BR112015013625A2 (pt) | adjuvante de vacinação, preparação e vacinas contendo o mesmo |